An analysis of the outcomes of treatment of small cell lung cancer in the elderly

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 2, 1997, Pages 160-164

  Tebbutt, N C ^a,b   Snyder, R D ^a   Burns, W I ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

chemotherapy; elderly; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; AUSTRALIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ABSCESS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHYSICAL PERFORMANCE; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0030968660     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb00932.x     Document Type: Article

References (19)

1. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer 1994; 74: 2208-14.
2. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47; 207-14.
3. Victorian Year Book 1996. Australian Bureau of Statistics, 1996.
4. Victorian Cancer Registry. 1990 Statistical Report. Anti Cancer Council of Victoria, 1993.
5. Brown JS, Eraut D, Trask C, Davison AG. Age and the treatment of lung cancer. Thorax 1996; 51: 557-60.
6. Sagman U, Maki E, Evans WK et al. Small-cell carcinoma of the lung: Derivation of a prognostic staging system. J Clin Onc 1991; 9: 1639-49.
7. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580-Patient Southwest Oncology Group Data Base. J Clin Onc 1990; 8: 1563-74.
8. Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 1983; 52: 1986-92.
9. Raghavan D, Bishop JF, Stuart-Harris R et al. Carboplatin-containing regimens for small cell lung cancer: Implications for management in the elderly. Sem Oncol 1992; 19 (Suppl. 2): 12-6.
10. Shepherd FA, Amdemichael E, Evans WK et al. Treatment of small cell lung cancer in the elderly. J Am Ger Soc 1994; 42: 64-70.
11. Findlay MPN, Griffin A-M, Raghavan D et al. Retrospective review of chemotherapy for small cell lung cancer in the elderly: Does the end justify the means? Eur J Cancer 1991; 27: 1597-601.
12. Goss GD, Logan D, Maroun J, Stewart D, Yau J, Evans WK. Chemotherapy in elderly patients with small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 1992; 11: 290 (Abstr. 969).
13. Dajczman E, Fu LY, Small D, Wolkove M, Kreisman H. Treatment of small cell lung carcinoma in the elderly. Cancer 1996; 77: 2033-8.
14. Siu LL, Shepherd FA, Murray N, Feld R, Pater J, Zee B. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Onc 1996; 14: 821-8.
15. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst 1994; 86: 1766-70.
16. Quoix EA, Giaccone G, Jassem J et al. Epirubicin in previously untreated patients with small cell lung cancer: A phase II study by the EORTC Lung Cancer Cooperative Group. Eur J Cancer 1992; 28A: 1667-70.
17. Tummarello D, Isidori P, Pasini F et al. Teniposide as single drug therapy for elderly patients affected by small cell lung cancer. Eur J Cancer 1992; 28A: 1081-4.
18. Carney D, Keane M, Grogan L. Oral etoposide in small cell lung cancer. Semin Oncol 1992; 19 (Suppl. 14): 40-4.
19. Medical Research Council Lung Cancer Working Party. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Lancet 1996; 348: 563-6.